Cambridge Tests Tech Transfer

LONDON—All over Europe, politicians and planners are wondering if small, science-based companies can regenerate fading economies hit by the decline in such traditional industries as shipbuilding and steelmaking. In their search for answers, Cambridge, England, has emerged as a living laboratory to test the economic value of such businesses and the process through which academic innovations are transferred to industry. Cambridge, which as little as 10 years ago was known primarily for its c

Written byPeter Marsh
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In their search for answers, Cambridge, England, has emerged as a living laboratory to test the economic value of such businesses and the process through which academic innovations are transferred to industry.

Cambridge, which as little as 10 years ago was known primarily for its centuries-old university, today enjoys the biggest concentration of small, technology-based businesses in Europe. The area is often compared to the assortment of high-tech industries in California's Silicon Valley and the Route 128 corridor around Boston.

The city and its environs boast more than 400 such concerns, with from 30 to 50 new firms appearing every year. Many of the businesses, which employ about 12 percent of the local work force, have strong links with the technical departments (mainly computing and engineering) of Cambridge University. The best known companies include Cambridge Instruments, Laser-Scan, Acorn Computer (now a division of Olivetti of Italy), Cambridge Consultants, Marshall and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies